Bio-Techne

TECH · Health Care · Market cap $11.3B

Q3 FY26 Jan 1 – Mar 31, 2026 reported May 6, 2026

Revenue$0.31B −2% year over year

Gross profit$0.21B

Operating profit$0.08B

Net profit$0.05B 16% margin

Numbers and detail

All figures in billions of U.S. dollars, for Q3 FY26 (period ends Mar 31, 2026).
Item	Value	Share of revenue	Year over year
Revenue	0.31	100%	−2%
Consumables	0.26	83%	+0%
Instruments	0.03	9%	+6%
Service	0.02	7%	−21%
Royalty	0.01	2%	−1%
Cost of revenue	−0.10	33%
Gross profit	0.21	67% margin	−1pp
SG&A	−0.11	35%	−13pp
Other	−0.02	8%	+0pp
Operating profit	0.08	24% margin	+12pp
Tax	−0.02
Interest & other costs	−<0.01
Net profit	0.05	16%	+9pp

Quarter by quarter

So far we hold one set of results. Another one arrives with the next filing.

Quarter	Period	Reported	Revenue	Year over year	Operating margin	Net profit	Net margin
Q3 FY26	Jan 1 – Mar 31, 2026	May 6, 2026	$0.31B	−2%	24%	$0.05B	16%